Aim. The aim of the study was to identify the features of a new coronavirus infection in patients with chronic obstructive pulmonary disease (COPD), bronchial asthma (BA), and cardiovascular disease (CVD).Materials and Methods. The retrospective study included 58 patients with novel coronavirus infection, which were divided into four groups: group 1 comprised 12 patients with COPD and CVD; group 2 comprised 15 patients with BA and CVD; and group 3 comprised 31 patients with CVD only. All patients underwent a clinical examination, complete blood count, biochemical blood examination, coagulation testing, serum ferritin test, and multi-slice computed tomography.Results. The severity of dyspnea was greater in patients with COPD/CVD compared with BA/CVD, and in patients without bronchopulmonary pathology. The frequency of desaturation was the lowest in BA/CVD group compared with COPD/CVD and COPD/BA/CVD. A lower level of saturation was observed in COPD/CVD group in comparison with BA/CVD. The extent of lung damage also prevailed in group with COPD/CVD compared with patients without bronchopulmonary pathology. Patients with CVD only demonstrated the lowest level of leukocytes in contrast with all other study groups. However, the platelet count prevailed in the CVD group compared with the COPD/CVD group. Serum ferritin in patients with COPD/CVD was higher than in the AD/CVD group.Conclusion. Patients with COPD had more severe coronavirus infection due to severity of dyspnea, low saturation indicators, high values of ferritin, and greater severity of lung damage according to computed tomography. Patients with asthma were prone to a less severe course of coronavirus infection due to less dyspnea, rare episodes of desaturation, high saturation rates, and low ferritin values.
9 July 2023 in Siberian Journal of Clinical and Experimental Medicine
The lecture synthesizes and analyzes the findings of research concerning the impact of sleep disordered breathing (SDB) on the progression of the most prevalent chronic non-infectious lung diseases (CNLDs). SDB, including conditions, such as snoring, sleep hypoventilation syndrome, and obstructive and central sleep apnea syndrome, constitutes a significant medical concern due to its high prevalence and adverse health consequences. SDB is regarded as an independent risk factor for the development and progression of a range of CNLDs. Timely diagnosis and management of SDB may serve as an effective preventive measure against severe manifestations and complications associated with this group of diseases.
12 January 2026 in Siberian Journal of Clinical and Experimental Medicine
Aim: To determine the influence of type 2 diabetes mellitus (DM 2) on the functional state of alveolar-capillary permeability (ACP) and inflammatory process intensity in community-acquired pneumonia (CAP). Material and Methods . Patients hospitalized with CAP and DM 2 (n = 24), CAP (n = 24) and DM 2 (n = 32) were enrolled in a singlecenter cross-sectional study. All patients underwent: ventilation scintigraphy to assess the state of ACP, biochemical study of oxidative processes in blood plasma using spectrophotometry. The examination was performed on the 1st-3rd day from the beginning of their hospitalization. Results. A statistically significant increase in ACP at the 30th minute of the examination was observed in both the affected lung (39.2%) and the intact lung (34.1%) in CAP + DM2 patients vs. 30.9% and 28.2% in CAP patients and 23.2% in DM 2 patients. The highest production of trypsin-like proteinases (TLPs, 153.3 BAEE/min·mL), elastase-like proteinases (ELPs, 130.7 BAEE/min·mL), thiobarbituric acid (TBARS, 8.4 μmol/mL), and bityrosine (12*10–3 units) was observed in CAP + DM 2 patients with the minimum activity of α1-proteinase inhibitor (α1PI) of 28.5 IU/mL vs. all comparison groups. The correlation analysis revealed strong direct relations between the ACP value and the activity of TLPs, ELPs, TBARS and negative relations with α1PI. Conclusion. The peculiarity of pulmonary dysfunction manifestation in CAP+DM 2 patients consists in increased ACP both in the affected and intact lungs. The inflammatory process in CAP + DM 2 patients is characterized by the minimum activity of the inhibitor and the maximum activity of proinflammatory enzymes. These correlations testify to a systemic inflammation being more pronounced when the two nosologies occur simultaneously, which affects the state of ACP.
The lecture considers the results of research conducted by Russian and foreign scientists concerning the characteristics of all types of metabolic disorders and hormonal imbalance in undifferentiated connective tissue dysplasia (CTD). Understanding the role of hormonal and metabolic disorders in the development and course of diseases associated with CTD is of great importance for the development of pathogenetically grounded algorithms for the diagnosis, treatment, and prevention of emergency conditions.
Chronic obstructive pulmonary disease (COPD) is a severe respiratory condition associated with a markedly increased risk of lung cancer (LC), which develops in 10–30% of COPD patients. Currently, no validated criteria exist for stratifying COPD clinical phenotypes according to their risk of malignant transformation. A major limitation in addressing this issue is the restricted accessibility of biological material from precancerous bronchial epithelial lesions in patients. This pilot study aimed to investigate the methylation profile of microRNA genes associated with precancerous changes in peripheral blood of individuals with COPD, as a potential non-invasive approach for risk assessment. We assessed the methylation levels of six microRNA genes (MIR492, MIR650, MIR487A, MIR6132, MIR1202, and MIR634) in the peripheral blood mononuclear cells obtained from the COPD patients. Targeted bisulfite massively parallel sequencing was performed on the SurfSeq 5000 platform (paired-end, 2 × 150 bp). Statistical analysis revealed significant differences in methylation levels at specific CpG sites between healthy controls and COPD patients: for MIR487A (position_id:chr14:101051905+, p = 0.001) and for MIR650 (position_id: chr22:22822637+, p = 0.012). Additionally, a trend towards significance was observed for MIR6132 (position_id:chr7:117019932+, p = 0.070). These findings suggest that the methylation status of MIR487A and MIR650 may serve as potential epigenetic markers for identifying individuals with COPD at higher risk of precancerous transformation. Further validation in larger cohorts is warranted to confirm their clinical utility.